QV Bioelectronics
PrivateLast Round
Series A
Jan 21, 2026
Total Funding Raised
$15.67M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
QV Bioelectronics is a medical devices company developing an implantable electric field therapy (EFT) device for the treatment of aggressive brain tumours.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QV Bioelectronics Comparables
Compare QV Bioelectronics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coherence Neuro | 84% | |
| LifeBridge Innovations, PBC | 80% | |
| Alpheus Medical | 79% |
QV Bioelectronics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 21, 2026 | ||||
| Grant | May 7, 2025 | ||||
| Grant | Aug 30, 2024 | ||||
| Grant | May 7, 2024 | ||||
| Grant | Aug 30, 2023 | ||||
Grant | Apr 3, 2023 |
Key People
Founding team and executive leadership
QV Bioelectronics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant, Series A, Pre Seed |
| Consilience Ventures | Seed |
| Fink Family Office | Early Funding |
| Elbow Beach Capital | Early Funding |
| Empirical Ventures | Series A |
| Elbow Beach Capital | Early Funding |
| Northern Gritstone | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 48% MoM, reaching 1.3K.
- Apr 16, 2026
Grew 20% QoQ, from 15 to 18 employees.
QV Bioelectronics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about QV Bioelectronics's valuation, stock price, and market status.
Is QV Bioelectronics a public or private company?
QV Bioelectronics is a private company.
What is the current stock price of QV Bioelectronics?
QV Bioelectronics is a private company with no public stock price. No recent secondary market data is available.
How much is QV Bioelectronics worth (valuation)?
Valuation information for QV Bioelectronics is not publicly available.
Can I buy QV Bioelectronics stock?
QV Bioelectronics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was QV Bioelectronics's last funding round?
QV Bioelectronics's most recent funding round was Grant on May 7, 2024.
Who are the main investors in QV Bioelectronics?
Key investors in QV Bioelectronics include Fink Family Office.
Will QV Bioelectronics IPO soon?
No public IPO plans have been announced for QV Bioelectronics.
How can I track QV Bioelectronics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor QV Bioelectronics's secondary market activity and sign up for updates.